SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-166729
Filing Date
2011-06-16
Accepted
2011-06-16 17:00:54
Documents
2
Period of Report
2011-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K d8k.htm 8-K 19796
2 PRESS RELEASE dex991.htm EX-99.1 5263
  Complete submission text file 0001193125-11-166729.txt   26670
Mailing Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011 4253681050
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31982 | Film No.: 11915629
SIC: 2835 In Vitro & In Vivo Diagnostic Substances